Bright B. Simons is a technology innovator, development activist and social entrepreneur. As an Executive at Accra-based think tank IMANI, he contributes to activities that challenge received wisdom about Africa's development challenges. As President of the mPedigree Network, he invented a system that empowers consumers to instantly verify with a free text message whether their medicines are safe and not counterfeit, while providing pharmaceutical companies previously inaccessible market intelligence. Counterfeit medicines are reckoned by experts to kill at least 2000 people daily in the developing world and can constitute more than 40% of all medicines on sale in some countries. Bright is a member of the World Economic Forum's Global Agenda Councils and Technology Pioneers Community. He is also a Tech Museum Laureate and a Brain Trust member of the Evian Group at IMD, widely considered Europe's foremost business school. In the course of Bright's various activities he has addressed many of the Fortune 100 CEOs, and been cited in many of the world's most prominent publications, such as the Wall Street Journal, the Economist, the New York Times, the Asian Times, Fast Company, and Time magazine. In 2010, he was conferred with an Archbishop Tutu Award.

About mPedigree:
mpedigree anticipates a future in which counterfeit medicines would be a thing of the past. A future in which infants shall not be poisoned because of their parents were hoodwinked into buying dangerous chemicals packaged to look like real medicines. We work with pharmaceutical companies, telecom operators, major technology providers, like Hewlett Packard, and regulatory agencies, like Nigeria's NAFDAC, to develop ecosystems for the securing of each pack of medicine through the application of unique IDs to the packaging of these medicines. Consumers and patients are able to easily unveil these IDs when they buy the pack and text-message the characters forming the ID to a special, 4-digit, phone number available in multiple countries for a quick response, in a few seconds actually, from a central, secure, regulated, registry that the pack of medicine is an original from the legitimate brand owner, has been certified through rigorous procedures, and has not been blacklisted for any reason. This simple process should help restore trust in the public health systems of emerging societies, help stem the rise of multiple-resistant disease-causing micro-organisms and contribute to reducing the more than 2000 daily deaths attributed to counterfeit and fake medicines in vulnerable societies. 




Speakers at YIFP
Find India Future of Change on FaceBook
Terms and Conditions Copyright © 2012. InDialogues - Conversations With The World